NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/12/2026
Back to search
Official data from USPTO
IDS I10
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/02/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10
Filing date
10/23/2017
Registration date
12/25/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
GB
Examiner
DELGIZZI, RONALD ERNEST
Current location
Historical data usage
Mark description
The mark consists of the literal elements "IDS I10" represented in stylized font wherein the letters "IDS" and "I" appear in lower font in the color gray, and the dots over each letter "I" appear in red. The numbers "1" and "0" appear in gray.
Holders and representatives
Holders
Immunodiagnostic Systems Limited
Representatives
Kevan L. Morgan Seed IP Law Group LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use other than medicalresearch or scientific investigation in the areas of immunochemistryimmunologyclinical chemistrybiochemistrymicrobiologyhematologyhemostasis; diagnostic test reagentschemical and biochemical reagentspreparations for determining the presence or concentration of an analyte for clinicalscientific or research purposes; diagnostic preparations for scientific or research use; assays and reagents for research purposes; biological and biochemical reagentsused for non-medical purposesfor research and commercial use in the nature of biochemical or biological analysis
Class 5
Reagents for use in diagnostic testsdiagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detectiondiseases and disorders in the areas of endocrinologyclinical chemistryautoimmunityinfectious diseasesallergyhemostasiscoagulationhematologyimmunologytherapeutic drug monitoringoncology markersother biomarkersimmunochemistry for medical purposes; chemical diagnostic reagents for medical use; diagnostic preparationsdiagnostic reagents for medical use; diagnostic testing materialsimmunoassays and chemistry tests for measuring analytes for use in diseases and disorders in the areas of endocrinologyclinical chemistryautoimmunityinfectious diseasesallergyhemostasiscoagulationhematologyimmunologytherapeutic drug monitoringoncology markersother biomarkersimmunochemistry for medical use; reagents for use in diagnostic tests; chemical preparations for testing blood for use in disease detectiondiseases and disorders in the areas of endocrinologyclinical chemistryautoimmunityinfectious diseasesallergyhemostasiscoagulationhematologyimmunologytherapeutic drug monitoringoncology markersother biomarkersimmunochemistry for medical purposes; diagnostic reagents for medical use for sale in kit formnamely diagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detectiondiseases and disorders in the areas of endocrinologyclinical chemistryautoimmunityinfectious diseasesallergyhemostasiscoagulationhematologyimmunologytherapeutic drug monitoringoncology markersother biomarkersimmunochemistry
Class 9
Instrumentsscientific instrumentsautomated analyzers for testing and analyzing chemical and biological substances for the presenceabsence or quantity of biological analytes or target chemicalsinstruments using automated detection methods for detecting and identifying chemical and biological substancesnot for medical purposesfor testingprocessing or detecting biological samples ; computer software for use in analyzing and managing biological data
Class 10
Medical diagnostic apparatus for medical purposes* specifically * diagnostic instruments for medical use in immunoassay and clinical chemistry testing such as electromagnetic medical diagnostic imaging apparatus; medical diagnostic testing instruments for use in immunoassay medical proceduresmedical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing* including * cytology and cell-based testing; medical diagnostic instrumentsmedical instrument for cardiovascular diagnostics; blood testing apparatus
Publications
History of USPTO decisions and trademark events.
42 publications found
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
05/12/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/04/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/20/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/12/2026
PR71
POST REGISTRATION ACTION MAILED - SEC.71
11/14/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/06/2025
PR71
POST REGISTRATION ACTION MAILED - SEC.71
05/20/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2025
ES71
TEAS SECTION 71 RECEIVED
12/23/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/26/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/08/2019
FIMP
FINAL DISPOSITION PROCESSED
04/08/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/25/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/19/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/19/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
ALIE
ASSIGNED TO LIE
09/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2018
RFNT
REFUSAL PROCESSED BY IB
03/02/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/12/2018
RFRR
REFUSAL PROCESSED BY MPU
02/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
02/09/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/08/2018
CNRT
NON-FINAL ACTION WRITTEN
02/07/2018
DOCK
ASSIGNED TO EXAMINER
02/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2018
Continuous trademark protection
Get notified about every new filing that threatens IDS I10 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.